203 related articles for article (PubMed ID: 9240639)
1. Adjuvant and salvage irradiation following radical prostatectomy for prostate cancer.
Morris MM; Dallow KC; Zietman AL; Park J; Althausen A; Heney NM; Shipley WU
Int J Radiat Oncol Biol Phys; 1997 Jul; 38(4):731-6. PubMed ID: 9240639
[TBL] [Abstract][Full Text] [Related]
2. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.
Vargas C; Kestin LL; Weed DW; Krauss D; Vicini FA; Martinez AA
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):714-24. PubMed ID: 15708249
[TBL] [Abstract][Full Text] [Related]
3. Salvage radiotherapy for biochemical and clinical failures following radical prostatectomy.
Do T; Parker RG; Do C; Tran L; Do L; Dolkar D
Cancer J Sci Am; 1998; 4(5):324-30. PubMed ID: 9815297
[TBL] [Abstract][Full Text] [Related]
4. Effect of higher radiation dose on biochemical control after radical prostatectomy for PT3N0 prostate cancer.
Valicenti RK; Gomella LG; Ismail M; Mulholland SG; Petersen RO; Corn BW
Int J Radiat Oncol Biol Phys; 1998 Oct; 42(3):501-6. PubMed ID: 9806507
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome of patients with prostate cancer and pathologic seminal vesicle invasion (pT3b): effect of adjuvant radiotherapy.
Lee HM; Solan MJ; Lupinacci P; Gomella LG; Valicenti RK
Urology; 2004 Jul; 64(1):84-9. PubMed ID: 15245941
[TBL] [Abstract][Full Text] [Related]
6. PSA based review of adjuvant and salvage radiation therapy vs. observation in postoperative prostate cancer patients.
Peschel RE; Robnett TJ; Hesse D; King CR; Ennis RD; Schiff PB; Wilson LD
Int J Cancer; 2000 Feb; 90(1):29-36. PubMed ID: 10725855
[TBL] [Abstract][Full Text] [Related]
7. Treatment results of adjuvant radiotherapy and salvage radiotherapy after radical prostatectomy for prostate cancer.
Wadasaki K; Kaneyasu Y; Kenjo M; Matsuura K; Murakami Y; Hashimoto Y; Ito K; Kiriu H; Ito A
Int J Clin Oncol; 2007 Feb; 12(1):37-41. PubMed ID: 17380439
[TBL] [Abstract][Full Text] [Related]
8. Serum PSA evaluations during salvage radiotherapy for post-prostatectomy biochemical failures as prognosticators for treatment outcomes.
Do T; Dave G; Parker R; Kagan AR
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1220-5. PubMed ID: 11483332
[TBL] [Abstract][Full Text] [Related]
9. Achieving an undetectable PSA after radiotherapy for biochemical progression after radical prostatectomy is an independent predictor of biochemical outcome--results of a retrospective study.
Wiegel T; Lohm G; Bottke D; Höcht S; Miller K; Siegmann A; Schostak M; Neumann K; Hinkelbein W
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1009-16. PubMed ID: 18963539
[TBL] [Abstract][Full Text] [Related]
10. Importance of margin extent as a predictor of outcome after adjuvant radiotherapy for Gleason score 7 pT3N0 prostate cancer.
Valicenti RK; Chervoneva I; Gomella LG
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1093-7. PubMed ID: 15001249
[TBL] [Abstract][Full Text] [Related]
11. Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy.
Kupelian PA; Katcher J; Levin HS; Klein EA
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1043-52. PubMed ID: 9169811
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant and salvage radiotherapy after radical prostatectomy for prostate cancer.
Taylor N; Kelly JF; Kuban DA; Babaian RJ; Pisters LL; Pollack A
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):755-63. PubMed ID: 12788182
[TBL] [Abstract][Full Text] [Related]
13. Positive resection margin and/or pathologic T3 adenocarcinoma of prostate with undetectable postoperative prostate-specific antigen after radical prostatectomy: to irradiate or not?
Choo R; Hruby G; Hong J; Hong E; DeBoer G; Danjoux C; Morton G; Klotz L; Bhak E; Flavin A
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):674-80. PubMed ID: 11849789
[TBL] [Abstract][Full Text] [Related]
14. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
[TBL] [Abstract][Full Text] [Related]
15. The efficacy of early adjuvant radiation therapy for pT3N0 prostate cancer: a matched-pair analysis.
Valicenti RK; Gomella LG; Ismail M; Strup SE; Mulholland SG; Dicker AP; Petersen RO; Newschaffer CJ
Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):53-8. PubMed ID: 10477006
[TBL] [Abstract][Full Text] [Related]
16. Limited suppression of prostate-specific antigen after salvage radiotherapy for its isolated elevation after radical prostatectomy.
Egawa S; Matsumoto K; Suyama K; Soh S; Kuwao S; Iwamura M
Urology; 1999 Jan; 53(1):148-54. PubMed ID: 9886604
[TBL] [Abstract][Full Text] [Related]
17. Preirradiation PSA predicts biochemical disease-free survival in patients treated with postprostatectomy external beam irradiation.
Crane CH; Rich TA; Read PW; Sanfilippo NJ; Gillenwater JY; Kelly MD
Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):681-6. PubMed ID: 9336150
[TBL] [Abstract][Full Text] [Related]
18. Durable efficacy of early postoperative radiation therapy for high-risk pT3N0 prostate cancer: the importance of radiation dose.
Valicenti RK; Gomella LG; Ismail M; Mulholland SG; Strup S; Petersen RO; Corn BW; Lu JD
Urology; 1998 Dec; 52(6):1034-40. PubMed ID: 9836551
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant and salvage radiotherapy after radical prostatectomy.
Höcht S; Wiegel T; Schostak M; Hinkelbein W
Onkologie; 2002 Jun; 25(3):201-6. PubMed ID: 12119453
[TBL] [Abstract][Full Text] [Related]
20. Radiotherapy after radical prostatectomy: does transient androgen suppression improve outcomes?
King CR; Presti JC; Gill H; Brooks J; Hancock SL
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):341-7. PubMed ID: 15145146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
